Terrence J. Sacchi, MD

Original Contribution

Three-year Survival after Percutaneous Coronary Intervention According to Appropriateness Criteria for Revascularization

11/05/2009

Sanjay Bose , MD;

Sorin J. Brener , MD;

Terrence J. Sacchi , MD;

Salman A. Haq , MD;

ABSTRACT: Objectives. We sought to compare 3-year outcomes of percutaneous coronary intervention (PCI) according to recently published appropriateness criteria for PCI. Background. The choice of revascularization between PCI and coronary...

ABSTRACT: Objectives. We sought...

11/05/2009

Journal of Invasive Cardiology

Original Contribution

Relationship Between the Angiographically Derived SYNTAX Score and Outcomes in High-Risk Patients Undergoing Percutaneous Coronary Intervention

01/27/2011

Terrence J. Sacchi , MD;

Ashok J. Prasad , MD;

Sorin J. Brener , MD;

Raushan Abdula , MD;

ABSTRACT: Numerous risk scores have been designed to predict the outcome of percutaneous coronary intervention (PCI). The Synergy between Percutaneous Coronary Intervention with Taxus and Cardiac Surgery (SYNTAX) score has been shown to...

ABSTRACT: Numerous risk scores...

01/27/2011

Journal of Invasive Cardiology

Original Contribution

Correlation Between Markers of Reperfusion and Mortality in ST-Elevation Myocardial Infarction: A Systematic Review

10/27/2014

Sudhakar Sattur , MD, MHSA;

Bilal Sarwar , MD;

Terrence J. Sacchi , MD;

Sorin J. Brener , MD;

Early reperfusion improves STEMI outcomes. Reperfusion can be assessed using angiographic (Thrombolysis in Myocardial Infarction flow grade or myocardial blush grade) or electrocardiographic markers (ST-segment recovery). Our aim was to...

Early reperfusion improves STEMI...

10/27/2014

Journal of Invasive Cardiology

Ticagrelor vs Clopidogrel in Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention: Insights From a Single Institution Registry

07/14/2019

Sorin J. Brener , MD;

Terrence J. Sacchi , MD;

Venkatesh Alapati , MD;

Max M. Benson , MD;

Doris Chan , DO;

Gregory J. Cunn , MD;

Saadat Khan , MD;

Issa Kutkut , MD;

John P. O'Laughlin , MD;

Chockalingham Arun Narayanan , MD;

We identified ACS patients from our institutional registry who underwent PCI and received either ticagrelor or clopidogrel and compared 1-year all-cause death rates.

We identified ACS patients from...

07/14/2019

Journal of Invasive Cardiology

Original Contribution

The SYNTAX II Score Predicts Mortality at 4 Years in Patients Undergoing Percutaneous Coronary Intervention

06/15/2018

Amol Raizada , MD;

Terrence J. Sacchi , MD;

Venkatesh Alapati , MD;

Doris Chan , DO;

John P. O'Laughlin , MD;

Akanibo Da-Wariboko , MD;

Sorin J. Brener , MD;

Yousef Kaid , MD;

Chockalingham Arun Narayanan , MD;

Yevgeniy Latyshev , MD;

Amr Moussa , MD;

Gautam Verma , MD;

We evaluate the utility of the SYNTAX II score, which incorporates angiographic and clinical parameters, for risk stratification and prediction of 4-year mortality in 831 real-world patients.

We evaluate the utility of...

06/15/2018

Journal of Invasive Cardiology

A Novel Risk Score to Predict One-Year Mortality in Patients Undergoing Complex High-Risk Indicated Percutaneous Coronary Intervention (CHIP-PCI)

04/01/2021

Terrence J. Sacchi , MD;

Gregory J. Cunn , MD;

Issa Kutkut , MD;

Pankil H. Desai , MD;

Mouzamjha Faroqui , MD;

Sorin J. Brener , MD;

Le Dung Ha , MD;

Garima Handa , MD;

Adnan Raza , MD;

Our aim was to identify patients undergoing complex, high-risk indicated percutaneous coronary intervention (CHIP-PCI) and compare their outcomes with non-CHIP patients. We created a CHIP score to risk stratify these patients.

Our aim was to identify patients...

04/01/2021

Journal of Invasive Cardiology